Opus Genetics, Inc. (IRD)
(Delayed Data from NSDQ)
$1.07 USD
-0.04 (-3.60%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $1.09 +0.02 (1.87%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2025
Time: -- |
6/2025 | $-0.25 | 0.00% |
Earnings Summary
For their last quarter, Opus Genetics, Inc. (IRD) reported earnings of -$0.32 per share, beating the Zacks Consensus Estimate of $-0.34 per share. This reflects a positive earnings surprise of 5.88%. Look out for IRD's next earnings release expected on August 12, 2025. For the next earning release, we expect the company to report earnings of -$0.25 per share, reflecting a year-over-year increase of 16.67%.
Earnings History
Price & Consensus
Zacks News for IRD
Opus Genetics, Inc. (IRD) Reports Q1 Loss, Tops Revenue Estimates
IRD: What are Zacks experts saying now?
Zacks Private Portfolio Services